| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.5746 | 43 |
| GSM780708 | Untreated after 4 days (C2_1) | 50.9168 | 51 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.8298 | 54 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.0945 | 32 |
| GSM780720 | Untreated after 4 days (C2_2) | 57.4596 | 62 |
| GSM780721 | Untreated after 4 days (C3_2) | 51.3092 | 52 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 54.9107 | 59 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.4653 | 39 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.8803 | 26 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.6757 | 47 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.0353 | 37 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.1351 | 56 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 51.9064 | 54 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.5444 | 43 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.1313 | 56 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 53.7363 | 57 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.2781 | 49 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.5159 | 34 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.9801 | 41 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 54.8198 | 59 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.9256 | 27 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 57.1275 | 62 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 52.4403 | 55 |